Navigation Links
Pixantrone Granted Fast Track Designation by FDA for Relapsed,Indolent NHL Patients

Proposed Phase III Trial Has the Potential to Demonstrate an Effect on a Serious or Life Threatening Aspect of This Disease

SEATTLE, May 07, 2007 /PRNewswire-FirstCall/ -- Cell Therapeutics, Inc. (CTI) announced today it received fast track designation from the U.S. Food and Drug Administration (FDA) for pixantrone, a novel anthracenedione, being investigated for the potential treatment of relapsed or refractory indolent non-Hodgkin's lymphoma (NHL). In granting fast track, the FDA noted that "relapsed or refractory indolent NHL is a serious and life threatening condition and is generally considered incurable. Results from a phase I and phase III study in patients with relapsed and/or refractory indolent non-Hodgkin's lymphoma suggest that pixantrone is active in this disease." The FDA also noted that the proposed phase III trial in combination with fludarabine and rituximab "has the potential to demonstrate an effect on a serious or life threatening aspect of this disease."

Prior results demonstrated that the addition of pixantrone to a fludarabine/rituximab-based regimen in relapsed or refractory indolent NHL yielded a 70 percent confirmed response/unconfirmed response (CR/uCR) rate. In that phase I/II study the estimated median duration of response was 25 months (range 2.3 to 43 months) and the estimated progression-free survival (PFS) rate at three years was 50.4 percent. A phase III trial of rituximab compared to rituximab plus pixantrone in relapsed or refractory indolent NHL had a 61 percent overall improvement in time to tumor progression (TTP) compared to rituximab alone (395 days vs. 245 days). In that randomized trial, the median TTP estimate for pixantrone/rituximab was 13.2 months compared to 8.1 months for rituximab alone (hazard ratio 0.13, log rank p< 0.001). The overall response rate in the pixantrone/rituximab arm was 75 percent versus 33 percent in the rituximab arm with a CR rate of 30 percent in the pixantrone/rituximab arm versus 11 p
'"/>




Page: 1 2 3 4 5

Related medicine technology :

1. Cell Therapeutics, Inc. Management to Discuss Todays Announcement of Interim Pixantrone Study Results
2. Pixantrone Combination Therapy for First-line Treatment of Aggressive Non-Hodgkins Lymphoma Results in Reduction in Severe Toxicities Including Heart Damage When Compared to Doxorubicin-based Therapy
3. Publication on Pixantrone Preclinical Studies Demonstrates Reduced Cardiotoxicity Compared to Equiactive Doses of Doxorubicin and Mitoxantrone
4. Allos Therapeutics PDX Granted Orphan Medicinal Product Designation by the European Commission
5. Based on Up to 6 Years of Follow-Up, Biovest Announces Favorable Interim Blinded Data for Fast-Tracked Pivotal Phase 3 Clinical Trial of BiovaxID Anti-Cancer Vaccine for Non-Hodgkins Lymphoma
6. Accentia Biopharmaceuticals Announces Favorable Interim Blinded Data on SinuNase in Its Fast-Tracked Pivotal Phase 3 Clinical Trial for Chronic Sinusitis
7. Stanford Researchers Track Human Stem Cells Transplanted Into Rat Brain
8. Gloucester Pharmaceuticals Receives Fast Track Designation for Romidepsin in Peripheral T-Cell Lymphoma
9. Sirion Therapeutics Receives Orphan Drug Designation for Ophthalmic Drug to Treat Viral Eye Infection
10. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
11. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
Post Your Comments:
(Date:9/18/2014)... 18, 2014  Casen Buswell has a rare vascular condition ... His case is one of only 14 known cases of ... hospital in the United States , and ... with the dual wave-length laser, is Methodist Children,s Hospital, a ... . Using a laser available in South Texas ...
(Date:9/18/2014)... Sept. 18, 2014   Fruit Street Health ... initial seed round of funding. The ... by a series of individual investors, the majority of ... in the initial round are; Houston Cardiology Consultants ... Urologist Stacy Childs, Rapha Family Medicine Practice Owner ...
(Date:9/18/2014)... -- Pharma IQ, after huge ... Serialisation Countdown calendar to cover the years 2014 - ... shows the serialisation requirements around the globe and ... force. For companies dealing with international markets, ... "when" they will have to comply with new regulations ...
Breaking Medicine Technology:Methodist Children's Hospital In San Antonio, TX Only Hospital In The U.S. Treating Rare Vascular Condition With Dual Wave-Length Laser 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 2Fruit Street Health Secures First Round Of Seed Funding Led By Group Of Medical Industry And Technology Leaders 3Pharma IQ Displays Worldwide Serialisation Deadlines in their 2014 - 2018 Countdown Calendar 2
... Onyx Pharmaceuticals, Inc. (Nasdaq: ONXX ) today announced ... to discuss first quarter 2011 financial results, as well as ... at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time; 2:00 ... ended March 31, 2011 will be released earlier that day. ...
... 2011 / PRNewswire/ -- Fleming Pharmaceuticals, ... iodide product indicated for thyroid protection in radiation emergencies ... necessary to ramp up production to meet increased domestic ... an over-the-counter iodide solution which, when taken orally, saturates ...
Cached Medicine Technology:Onyx Pharmaceuticals Announces First Quarter 2011 Financial Results Teleconference and Webcast 2Fleming Pharmaceuticals Now Ready to Step Up Production of Nuclear Radiation Safeguard, ThyroShield® 2
(Date:9/18/2014)... 19, 2014 In 2003, ... Mission (Misión Barrio Adentro), which it hoped ... system (see Section 6.1.3.). In 2009, it ... Autonomous Service of Pharmaceutical Elaborations (Servicio Autónomo ... provides medicines at a cheaper rate than ...
(Date:9/18/2014)... Stealth Health Revolution co-founders, Montel ... Frank Davis, founder of Food for Health International ... to announce the new recipe book, "The Simple ... meals using Activz whole-food powders." The Simple ... the Stealth Health Revolution mission to ...
(Date:9/18/2014)... The National Institutes of Health (NIH) recently awarded the ... grant to the Los Angeles Biomedical Research Institute (LA ... a vaccine to protect patients from the healthcare-related infections, ... (MRSA). , The National Institute of Allergy and ... to LA BioMed infectious disease specialists John E. Edwards, ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 With the ... availability of products such as smart phones, tablets and ... in the way mobile devices are viewed these days. ... personal data to becoming a mode for creating and ... come a long way. , The complete ...
(Date:9/18/2014)... (PRWEB) September 18, 2014 Once again, ... favorite breakfast restaurants around the Valley to celebrate PJs ... on “World Egg Day”: Friday, October 10, 2014. The ... participating locations to benefit Arizona’s Children Association (AzCA) foster ... for dinner at each participating restaurant on October 10 ...
Breaking Medicine News(10 mins):Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 2Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 3Health News:Venezuela Pharmaceutical Market worth $22.2 billion with 12% CAGR by 2020 Says a New Report Available at MarketOptimizer.org 4Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 2Health News:Montel Williams and Frank Davis Announce New Whole-Food Nutrition Recipe Book, The Simple Scoop, at Natural Products Expo East In Baltimore 3Health News:LA BioMed receives NIH grant to study vaccine for hospital-acquired infections 2Health News:Transparency Market Research: M-health Market Study 2018 2Health News:Transparency Market Research: M-health Market Study 2018 3Health News:Transparency Market Research: M-health Market Study 2018 4Health News:October 10th Is 6th Annual PJs & Eggs: Hickman’s Family Farms and Breakfast Restaurants Partner to Benefit Arizona Foster Children 2
... fat in hot dogs, sausages, hamburgers and other foods with ... mystery of why hot dogs develop an unpleasant tough texture ... on their study appears in ACS, Journal of Agricultural ... explain that some brands of sausage (frankfurters) have been reformulated ...
... -- In a novel therapeutic approach to treating breast cancer, ... a clinical trial of a drug that targets tumor stem ... cells. But a handful of cancer stem cells are resistant ... into new tumor cells., A pilot study at Loyola found ...
... Serious traumatic injuries, including major burns, set off a ... percent of the cells, normal gene expression patterns. ... Journal of Experimental Medicine , members of a nationwide ... into the immune system response to serious injury, findings ...
... University Press (OUP) is pleased to announce the acquisition of two ... Journal of Chromatographic Science ( JCS ), from Preston ... these two titles sees the continued strengthening of the STM journal ... be able to take on the publishing for these two titles. ...
... 7 (HealthDay News) -- Some endurance athletes may suffer damage ... do not suggest that this type of exercise is unhealthy, ... four chambers in the heart involved in pumping blood. ... in one of four types of endurance events: marathons, endurance ...
... (irregular) schedule that includes three or more night shifts per ... that month, may have an increased risk of developing type ... or evenings, according to a new study led by researchers ... researchers found that extended years of rotating night shift work ...
Cached Medicine News:Health News:Novel approach to treating breast cancer shows great promise 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 2Health News:Traumatic injury sets off a 'genomic storm' in immune system pathways 3Health News:Oxford University Press acquires 2 journals from Preston Publications 2Health News:Marathons May Damage Part of Heart: Study 2Health News:Rotating night shift work linked to increased risk of Type 2 diabetes in women 2
... 1575 immunowash microplate washer ... needle position to perform ... maximize wash efficiency. This ... choice of wash that ...
... a solid made, manual plate washer ... for dispense and aspirate function ensure ... with a stand and all necessary ... used, as well as any bottles ...
MW 96-W1 microplate washer with one wash line....
Full automatic, ready-to-use strip washer....
Medicine Products: